UBS ETF In order to proceed, you must confirm that you are a qualified or institutional investor based in Finland.

The following information does not constitute distribution.

Please note that this webpage gives qualified investors access to the entire UBS ETF product offering. Therefore, some products on this webpage may NOT be authorized, recognised or registered for distribution neither in Finland, nor in your country or as the case may be nor in any other country. No distribution must be carried out for it. No marketing material must be handed out to clients on any occasion. The presentation of marketing material in client halls is strictly forbidden. Reference to these funds in client mailings must not be made. In case that you don't want or are not allowed to see the full ETF range, please do not proceed. Enter this site as Private Investor.

For marketing and information purposes by UBS.

For professional clients. The information and opinions contained in this document have been compiled or arrived at based upon information obtained from sources believed to be reliable and in good faith, but is not guaranteed as being accurate, nor is it a complete statement or summary of the securities, markets or developments referred to in the document. UBS AG and / or other members of the UBS Group may have a position in and may make a purchase and / or sale of any of the securities or other financial instruments mentioned in this document.

UBS funds under Luxembourg and Irish law

Before investing in a product please read the latest prospectus carefully and thoroughly. Units of UBS funds mentioned herein may not be eligible for sale in all jurisdictions or to certain categories of investors and may not be offered, sold or delivered in the United States. The information mentioned herein is not intended to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments. Past performance is not a reliable indicator of future results. The performance shown does not take account of any commissions and costs charged when subscribing to and redeeming units. Commissions and costs have a negative impact on performance. If the currency of a financial product or financial service is different from your reference currency, the return can increase or decrease as a result of currency fluctuations. This information pays no regard to the specific or future investment objectives, financial or tax situation or particular needs of any specific recipient. The details and opinions contained in this document are provided by UBS without any guarantee or warranty and are for the recipient's personal use and information purposes only. This document may not be reproduced, redistributed or republished for any purpose without the written permission of UBS AG. Source for all data and charts (if not indicated otherwise): UBS Asset Management

This document contains statements that constitute “forward-looking statements”, including, but not limited to, statements relating to our future business development. While these forward-looking statements represent our judgments and future expectations concerning the development of our business, a number of risks, uncertainties and other important factors could cause actual developments and results to differ materially from our expectations.

Prospectuses, simplified prospectuses or key investor information, the articles of association or the management regulations as well as annual and semi-annual reports of UBS funds are available in a language required by the local applicable law free of charge from UBS Asset Management, Regeringsgatan 38, S-11153 Stockholm.

© UBS 2019. The key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.

Back

UBS ETF (IE) CMCI ex-Agriculture SF UCITS ETF (USD) A-acc

Net asset value 129.9168 USD

Last update

05.12.2019

ISIN: IE00BZ2GV965

Asset Class:  Commodities

Investment instruments

Investment Type

Weight %

Government bonds

5.98

Foreign Currencies

0.96

Source: State Street, 05.12.2019

Government bond issuers

#

Country

Weight %

1

United Kingdom

100.00

Source: State Street, 05.12.2019

Currencies

#

Weight %

1

USD

94.02

2

GBP

5.98

3

JPY

0.00

4

EUR

0.00

Source: State Street, 05.12.2019

Balance fully funded Swap vs asset portfolio

Position Security Type

Weight %

Fully Funded Swap

4.60

Total Return Swap

95.40

Source: State Street, 05.12.2019

Eligible collateral under fully funded swap

The Swap Counterparty posts collateral that fulfils a strict quality and diversification criteria, which is defined by UBS ETFs plc. The collateral must also comply with the UCITS directive and ESMA Guidelines. The legal title of the collateral is transferred by the Swap Counterparty to the Fund and consists of bonds with a minimum assigned long term credit rating of "A", which are issued by the following G10 economies (France, Germany, Belgium, the Netherlands, Sweden, Canada, USA and the UK). Bonds issued by supranational organisations, with a minimum assigned long term credit rating of "AA" are also accepted.

Download all data as XLS File

Detailed positions

Security

ISIN

Weight %

UBS (IRL) SELECT MONEY MARKET FUND-USD-CAPITAL-P-DIST

IE00BWWCPM48

93.06

UNITED KINGDOM OF GREAT BRITAIN & N IRL 4.25000% 10-07.12.40

GB00B6460505

5.98

US DOLLAR

n.a.

0.96

JAPANESE YEN

n.a.

0.00

EURO CURRENCY

n.a.

0.00

The table above lists the securities that are used as collateral for the securities lent with UBS ETFs. The information presented was obtained from internal and external sources deemed reliable. However, we cannot provide any guarantee of their accuracy and completeness. It should be noted that securities lending is subject to a certain risk where the borrower does not return the borrowed securities according to his/her obligation, and where the value of the collateral provided does not cover the costs of repurchase of the securities. In this case, the borrower shall be liable for any claims arising from the securities lending and not covered by the sale of the securities concerned. Source: State Street, 05.12.2019

Disclaimer

For marketing and information purposes by UBS. Prospectuses, simplified prospectuses or key investor information, the articles of association or the management regulations as well as annual and semi-annual reports of UBS funds are available in a language required by the local applicable law free of charge from UBS Asset Management, Regeringsgatan 38, S-11153 Stockholm. "UBS AG (“UBS”) and Bloomberg Finance L.P. (“Bloomberg Finance”) (together, and/or any such other successor sponsor(s) to the Index, the “Index Provider”) make no representation or warranty, express or implied, regarding the appropriateness of investing in products referenced to the UBS Bloomberg Constant Maturity Commodity Index ("CMCI") , commodity products in general or of the ability of the CMCI to track commodity market performance. In determining the constituents of the CMCI and any amendment thereto, the Index Provider has no obligation to consider the needs of any counterparties that have products referenced to the CMCI. The Index Provider has all proprietary rights with respect to the CMCI. Any third party product based on or in relation to CMCI (“Product” or “Products”) may only be issued upon the prior written approval of UBS and Bloomberg Finance and upon the execution of a license agreement between UBS, Bloomberg Finance and the party intending to launch a Product. Neither UBS nor Bloomberg Finance, its affiliates and its and their respective partners, employees, subcontractors, agents, suppliers or vendors makes any representation or warranty, express or implied, to the holders of the Products or any member of the public regarding the advisability of investing in the Product or commodities generally or in futures particularly, or as to results to be obtained from the use of the CMCI or from the Product. Past performance of the CMCI is not necessarily indicative of future results. UBS Bloomberg, UBS Bloomberg Constant Maturity Commodity Index, UBS Bloomberg CMCI and CMCI are service marks of UBS and/or Bloomberg. All rights reserved. The Index Provider and its affiliates do not guarantee the quality, accuracy, and/or the completeness of the CMCI or any data included therein and shall not have any liability for any errors or omission or interruptions in the calculation and/or dissemination of the CMCI. The Index Provider and its affiliates makes no warranty, express or implied, as to results to be obtained by or from the use of the CMCI or any data included therein or for any other use (whether directly or via any product referenced thereto).Neither UBS nor Bloomberg Finance, its affiliates and its and their respective partners, employees, subcontractors, agents, suppliers and vendors, make any express or implied warranties, and to the extent permitted by law hereby expressly disclaim all warranties or merchantability or fitness for a particular purpose or use with respect to the CMCI or any data included therein. Without limiting any of the foregoing, to the extent permitted by law UBS and Bloomberg Finance, its affiliates and its and their respective partners, employees, subcontractors, agents, suppliers or vendors, disclaim any liability for any punitive, indirect, special, or consequential damages (including lost profits), even if notified of the possibility of such. To the extent permitted by law, Bloomberg Finance, its affiliates and its and their respective partners, employees, subcontractors, agents, suppliers and vendors shall have no liability or responsibility, contingent or otherwise, for any injury or damages, whether caused by the negligence of Bloomberg Finance, its affiliates or its or their respective partners, employees, subcontractors, agents, suppliers or vendors or otherwise, arising in connection with the Fund." Before investing in a product please read the latest prospectus carefully and thoroughly. The fund documentation is available free of charge in English and, where relevant, in one of the local language(s) where the fund is registered. The information and opinions contained in this document have been compiled or arrived at based upon information obtained from sources believed to be reliable and in good faith, but is not guaranteed as being accurate, nor is it a complete statement or summary of the securities, markets or developments referred to in the document. Members of the UBS Group may have a position in and may make a purchase and / or sale of any of the securities or other financial instruments mentioned in this document. Units of UBS funds mentioned herein may not be eligible for sale in all jurisdictions or to certain categories of investors and may not be offered, sold or delivered in the United States. The information mentioned herein is not intended to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments. Past performance is not a reliable indicator of future results. The performance shown does not take account of any commissions and costs charged when subscribing to and redeeming units. Commissions and costs have a negative impact on performance. If the currency of a financial product or financial service is different from your reference currency, the return can increase or decrease as a result of currency fluctuations. This information pays no regard to the specific or future investment objectives, financial or tax situation or particular needs of any specific recipient. The details and opinions contained in this document are provided by UBS without any guarantee or warranty and are for the recipient's personal use and information purposes only. This document may not be reproduced, redistributed or republished for any purpose without the written permission of UBS Asset Management Switzerland AG or a local affiliated company. Source for all data and charts (if not indicated otherwise): UBS Asset Management. More explanations of financial terms can be found at ubs.com/glossary © UBS 2019. The key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.